Effect of subcultivation of human bone marrow mesenchymal stem on their capacities for chondrogenesis, supporting hematopoiesis, and telomea length

被引:9
作者
Nakahara, M
Takagi, M
Hattori, T
Wakitani, S
Yoshida, T
机构
[1] Osaka Minami Natl Hosp, Dept Orthoped Surg, Kawachi Nagano, Osaka 5868521, Japan
[2] Shinshu Univ, Sch Med, Matsumoto, Nagano 3908621, Japan
[3] Osaka Univ, Int Ctr Biotechnol, Suita, Osaka 5650871, Japan
关键词
chondrogenesis; hematopoiesis; mesenchymal stem cell; population doubling level; subcultivation; telomere; UMBILICAL-CORD BLOOD; EX-VIVO EXPANSION; PROGENITOR CELLS; STROMAL CELLS; DIFFERENTIATION; GROWTH; PROLIFERATION; CYTOKINES; KINETICS; MATRIX;
D O I
10.1007/s10616-005-3752-9
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
Effects of subcultivation of human bone marrow mesenchymal stem cells on their capacities for chondrogenesis and supporting hematopoiesis, and telomea length were investigated. Mesenchymal stem cells were isolated from human bone marrow aspirates and subcultivated several times at 37 degrees C under a 5% CO2 atmosphere employing DMEM medium containing 10% FCS up to the 20th population doubling level (PDL). The ratio of CD45(-) CD10(+) cells among these cells slightly increased as PDL increased. However, there was no marked change in the chondrogenic capacity of these cells, which was confirmed by expression assay of aggrecan mRNA and Safranin O staining after pellet cell cultivation. The change in capacity to support hematopoiesis of cord blood cells was not observed among cells with various PDLs. On the other hand, telomere length markedly decreased as PDL increased at a higher rate than that at which telomere length of primary mesenchymal stem cells decreased as the age of donor increased.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 32 条
[1]
Changes of telomere length in children after hematopoietic stem cell transplantation [J].
Akiyama, M ;
Hoshi, Y ;
Sakurai, S ;
Yamada, H ;
Yamada, O ;
Mizoguchi, H .
BONE MARROW TRANSPLANTATION, 1998, 21 (02) :167-171
[2]
Akiyama M, 1998, EXP HEMATOL, V26, P781
[3]
TELOMERE LENGTH PREDICTS REPLICATIVE CAPACITY OF HUMAN FIBROBLASTS [J].
ALLSOPP, RC ;
VAZIRI, H ;
PATTERSON, C ;
GOLDSTEIN, S ;
YOUNGLAI, EV ;
FUTCHER, AB ;
GREIDER, CW ;
HARLEY, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10114-10118
[4]
Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy [J].
Banfi, A ;
Muraglia, A ;
Dozin, B ;
Mastrogiacomo, M ;
Cancedda, R ;
Quarto, R .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (06) :707-715
[5]
The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105) [J].
Barry, FP ;
Boynton, RE ;
Haynesworth, S ;
Murphy, JM ;
Zaia, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) :134-139
[6]
BROXMEYER HE, 1986, INT J CELL CLONING, V4, P378
[7]
Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO
[8]
2-F
[9]
Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells [J].
Bruder, SP ;
Kurth, AA ;
Shea, M ;
Hayes, WC ;
Jaiswal, N ;
Kadiyala, S .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1998, 16 (02) :155-162
[10]
MESENCHYMAL STEM-CELLS [J].
CAPLAN, AI .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1991, 9 (05) :641-650